Oslo, Norway – 28 February 2021 – Circa Group AS will increase prices for Levoglucosenone by 25%, and the Cyrene™ product portfolio in all markets by 15%, effective 1 March 2022, or as contracts allow.
Several factors drive the increases, including rising costs for most inputs and growing customer demand for supply.
Tony Duncan, CEO of Circa Group, said “Circa remains committed to exceeding customer expectations through the provision of novel products and services underpinned by value-based pricing and productivity improvement programmes for the long term. I am confident in the value that Cyrene™ creates for customers, especially for those building more sustainable products, and brand owners committed to transitioning to less carbon intensive processes by 2030.”
Cyrene™ is a safer and more sustainable bio-based alternative to common solvents such as NMP that has been classified as a Substance of Very High Concern (SVHC). Trialled in more than 1,000 industry and researcher applications with over 150 published scientific papers, Cyrene™ has been shown to outperform traditional toxic aprotic solvents in 20-30% of applications tested to date.